Nikhil Lalwani
Overview
Nikhil Lalwani received an average of $5M in total compensation, including $457K in salary, at ANI Pharmaceuticals between 2020 and 2021.
Source: SEC filings on March 25, 2022 and April 29, 2021.
Related executives
We found 11 more executives who work or worked at ANI Pharmaceuticals.
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
Christopher Mutz
ANI Pharmaceuticals
Head of Rare Disease
Ori Gutwerg
ANI Pharmaceuticals
Senior Vice President, Generics
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
Charlotte Arnold
ANI Pharmaceuticals